P4‐001: A Large, Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating RVT‐101, A Neurotransmitter‐Targeted Therapy, in Subjects with Mild‐to‐Moderate Alzheimer's Disease on Donepezil Treatment: Phase 3 Mindset Study Design. (1st July 2016)